A systematic approach toward the analysis of drug-DNA interactions using Raman spectroscopy: The binding of metal-free bleomycins A(2) and B-2 to calf thymus DNA
C. Rajani et al., A systematic approach toward the analysis of drug-DNA interactions using Raman spectroscopy: The binding of metal-free bleomycins A(2) and B-2 to calf thymus DNA, BIOPOLYMERS, 52(3), 1999, pp. 110-128
Bleomycins A2 and B2 are the active components in the antieoplastic drug Bl
enoxane. DNA is targeted by this drug in cancer cells and the mode of actio
n of this drug involves DNA binding, Ambiguity exists as to the way in whic
h bleomycin binds to DNA. Raman spectroscopy was used to examine both calf
thymus DNA and a bleomycin/DNA complex at two temperatures. A curvefitting
technique was applied to these spectra for a spectral region obscured by ma
ny overlapping bands associated with specific assigned nucleotide base resi
dues. Upon binding of bleomycin, several significant changes in bandwidth,
intensities, and frequencies relative to uncomplexed DNA were observed cons
istently at both higher (30 degreesC) and lower (19 degreesC) temperature.
The data presented here support at least a partial intercalation mode of bi
nding for bleomycin that is temperature dependent and more pronounced at th
e more physiologically relevant temperature of 30 degreesC. (C) 2001 John W
iley & Sons. Inc.